Recent publications · Crossref
5 total works indexed
- Nucleic acid detection with CRISPR-Cas13a/C2c2
· 2017 · cited 3,677x
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
· 2019 · cited 2,838x
- Sotorasib for Lung Cancers with
<i>KRAS</i>
p.G12C Mutation
· 2021 · cited 1,698x
- KRAS
<sup>G12C</sup>
Inhibition with Sotorasib in Advanced Solid Tumors
· 2020 · cited 1,585x
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
· 2015 · cited 1,182x
via Crossref · CC0